- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Diabetes pharmaceutical consumption in Slovakia 2005-2016
Diabetes pharmaceutical consumption in Slovakia 2005-2016
Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Slovakia from 2005 to 2016
by Conor Stewart,
last edited
Jun 20, 2019
This statistic displays the consumption of drugs used in diabetes in Slovakia from 2005 to 2016. The defined daily dosage of diabetes pharmaceuticals significantly increased in this period and amounted to 76.3 per 1,000 inhabitants per day in 2016.
Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Slovakia from 2005 to 2016
Loading statistic...
| Defined daily dosage per thousand inhabitants | |
|---|---|
| 2016** | 76.3 |
| 2015 | 75.2 |
| 2014 | 70.4 |
| 2013 | 65.6 |
| 2012 | 58 |
| 2011 | 61.3 |
| 2010 | 57.8 |
| 2009 | 50 |
| 2008 | 48.6 |
| 2007 | 43.4 |
| 2006 | 38 |
| 2005 | 36.5 |
| Defined daily dosage per thousand inhabitants | |
|---|---|
| 2016** | 76.3 |
| 2015 | 75.2 |
| 2014 | 70.4 |
| 2013 | 65.6 |
| 2012 | 58 |
| 2011 | 61.3 |
| 2010 | 57.8 |
| 2009 | 50 |
| 2008 | 48.6 |
| 2007 | 43.4 |
| 2006 | 38 |
| 2005 | 36.5 |
© Statista 2019
About this statistic
Source: OECD
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Conor Stewart,
last edited
Jun 20, 2019
This statistic displays the consumption of drugs used in diabetes in Slovakia from 2005 to 2016. The defined daily dosage of diabetes pharmaceuticals significantly increased in this period and amounted to 76.3 per 1,000 inhabitants per day in 2016.
- Source
- OECD
- Show further sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- November 2018
- Region
- Slovakia
- Survey time period
- 2005 to 2016
- Supplementary notes
-
* Defined daily dosage per 1,000 inhabitants per day.
**Break in time series
Source
- Source
- OECD
- Show further sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- November 2018
More information
- Region
- Slovakia
- Survey time period
- 2005 to 2016
- Supplementary notes
-
* Defined daily dosage per 1,000 inhabitants per day.
**Break in time series
Other statistics on the topic
+Pharmaceutical Products & Market
2018 list of global top 10 biotech and pharmaceutical companies based on net income
+Pharmaceutical Products & Market
Total global pharmaceutical R&D spending 2010-2024
+Pharmaceutical Products & Market
World pharmaceutical sales 2016-2018 by region
+Pharmaceutical Products & Market
Top therapeutic classes by global pharmaceutical sales 2018 estimates
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Global pharmaceutical industry"
- Overview
The most important statistics
- Revenue of the worldwide pharmaceutical market from 2001 to 2018 (in billion U.S. dollars)Pharmaceutical market: worldwide revenue 2001-2018
- Distribution of global pharmaceutical market revenue from 2010 to 2018, by regionGlobal pharmaceutical market - revenue distribution 2010-2018, by region
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*World pharmaceutical sales 2016-2018 by region
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*World pharmaceutical market distribution by submarket 2014-2018
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)Top therapeutic classes by global pharmaceutical sales 2018 estimates
- Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
- Companies and products
The most important statistics
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)2018 list of global top 10 biotech and pharmaceutical companies based on net income
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018Top pharmaceutical companies by capex growth in 2017/2018
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)Top pharmaceutical products by sales worldwide 2018
- Top generics manufacturers based on revenue in 2018 (in billion U.S. dollars)*Revenues of leading global generics manufacturers 2018
- Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars)Top cancer drugs based on revenue worldwide 2018
- Top companies by revenue
The most important statistics
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)Pfizer's total revenue 2006-2018
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*Pfizer's revenue by segment 2014-2018
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)Novartis' revenue 2007-2018
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)Novartis revenue 2014-2018 by segment
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)Roche Group's total sales 2006-2018
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)Roche Group's total sales by division 2013-2018
- R&D, patents, new products
The most important statistics
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)Total global pharmaceutical R&D spending 2010-2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*Patent expiration risks for total worldwide prescription drug revenue 2010-2024
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024Worldwide prescription drug revenue - market risk from patent expiration 2010-2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)Projected sales at risk due to patent expiry 2009-2022
- Number of new chemical or biological entities developed between 1992 and 2018, by region of originPharmaceutical industry - number of new substances 1992-2018
- Total number of novel drugs approved by CDER from 2008 to 2018Number of novel drugs approved annually by CDER 2008-2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Outlook
The most important statistics
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2022
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by countryPharmaceutical sector growth worldwide 2017-2030, by country
- Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)Global spending on medicines 2010-2023
- Projected expenditure on medicine of selected countries worldwide in 2023 (in billion U.S. dollars)Country comparison in spending on medicine 2023
- Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)Leading global pharmaceutical products and respective revenues 2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Studies
- Pharmaceutical industry in the Netherlands
- Pharmaceutical trends in Europe
- Oncology
- Prescribing for Diabetes, England 2007/08 to 2017/18
- CDER New Drugs Program: 2018 Update
- CDER 2018 New Drug Therapy Approvals
- Personalized medicine
- Prescribing for Diabetes, England 2005/06 to 2015/16
- CDER 2017 New Drug Therapy Approvals
- CDER New Drugs Program: 2017 Update
- Zoetis Annual Report 2018
- PAGB Annual Review 2017-2018
- CDER New Drug Review: 2016 Update
- Top 200 Products in the US Market by Sales, 2009
Statistics on "Global pharmaceutical industry"
- Revenue of the worldwide pharmaceutical market from 2001 to 2018 (in billion U.S. dollars)
- Distribution of global pharmaceutical market revenue from 2010 to 2018, by region
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)
- Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)
- Top generics manufacturers based on revenue in 2018 (in billion U.S. dollars)*
- Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars)
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)
- Number of new chemical or biological entities developed between 1992 and 2018, by region of origin
- Total number of novel drugs approved by CDER from 2008 to 2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
- Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2019 (in million U.S. dollars)
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by country
- Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)
- Projected expenditure on medicine of selected countries worldwide in 2023 (in billion U.S. dollars)
- Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)
- Consumption of drugs used for diabetes pharmaceuticals per 1,000 inhabitants per day* in Portugal from 2005 to 2017
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Austria from 2010 to 2016
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Denmark from 2005 to 2015
- Consumption of drugs used in diabetes per 1,000 inhabitants per day in Spain from 2004 to 2017
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Belgium from 2005 to 2016
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Czechia from 2005 to 2016
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Estonia from 2005 to 2017
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Germany from 2005 to 2016
- Consumption of drugs used diabetes per 1,000 inhabitants per day* in Hungary from 2005 to 2017
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Iceland from 2005 to 2017
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Luxembourg from 2005 to 2017
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in the Netherlands from 2005 to 2016
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Norway from 2005 to 2017
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Slovenia from 2006 to 2016
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in Slovakia from 2005 to 2016
- Consumption of drugs used for diabetes per 1,000 inhabitants per day* in the United Kingdom from 2007 to 2016
- Number of clinical trial starts for novel type 2 diabetes drugs in the U.S. from 2008 to 2017
- Clinical trial success rates of novel type 2 diabetes drugs between 2006 and 2015, by phase and indication
- Total sales value of drugs used in diabetes in Spain from 2004 to 2015 (in million euros)
- Total usage of dispensed diabetes medicines and goods in the Netherlands from 2013 to 2017*
- Number of dispensed diabetes medicines and goods in the Netherlands from 2013 to 2017*
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.